LeMaitre Vascular (STU:LHU) Moat Score: 5/10 (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:LHU LeMaitre Vascular Inc STU:LHU
98 GF Score
Price €70.00
GF Value €83.71
Valuation Modestly Undervalued
View Full Analysis

What is LeMaitre Vascular Moat Score?

LeMaitre Vascular STU:LHU +1.45% 98 Moat Score is 5 as of Aug. 08, 2026. GuruFocus rates STU:LHU with a GF Score™ of 98/100 and a GF Value™ of €83.71 (Modestly Undervalued). Among 837 Medical Devices & Instruments companies, LeMaitre Vascular ranks better than 91.16% on this metric.

LeMaitre Vascular has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

LeMaitre Vascular has Narrow Moat: LeMaitre Vascular has a solid narrow moat with its specialized medical devices and strong customer relationships. It benefits from some intellectual property and regulatory barriers, but lacks the scale and network effects for a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes LeMaitre Vascular might have Narrow Moat - Solid narrow moat.

LeMaitre Vascular  (STU:LHU) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

LeMaitre Vascular Moat Score Related Terms

STU:LHU vs PLSE, XRAY, ATRC: Moat Score Comparison

For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LeMaitre Vascular Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Moat Score distribution charts can be found below:

* The bar in red indicates where LeMaitre Vascular's Moat Score falls into.


STU:LHU
98GF Score
LeMaitre Vascular Inc STU:LHU
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
LeMaitre Vascular (STU:LHU) has a Moat Score of 5 as of Aug. 08, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, LeMaitre Vascular ranks #74 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 8.8%.
Is LeMaitre Vascular's Moat Score too high?
LeMaitre Vascular's current Moat Score is 5. Based on the distribution chart, LeMaitre Vascular ranks #74 out of 837 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, LeMaitre Vascular has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LeMaitre Vascular's Moat Score compare to PLSE and XRAY?
According to the Medical Devices & Instruments industry distribution chart, LeMaitre Vascular ranks #74 out of 837 companies for Moat Score. This places LeMaitre Vascular in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. LeMaitre Vascular's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LeMaitre Vascular stock overvalued right now?
Based on GuruFocus' analysis, LeMaitre Vascular (STU:LHU) is currently considered Modestly Undervalued. The stock's GF Value™ is €83.71, compared to a current price of €70.00 — trading 16.4% below its estimated fair value. The current Moat Score is 5. LeMaitre Vascular's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For LeMaitre Vascular (STU:LHU), the current Moat Score is 5 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LeMaitre Vascular (STU:LHU) Overvalued in 2026?

Based on GuruFocus' analysis, LeMaitre Vascular stock appears to be undervalued. The current stock price of €70.00 is trading 16.4% below its estimated GF Value™ of €83.71. GuruFocus considers LeMaitre Vascular to be Modestly Undervalued.

Key valuation signals for STU:LHU:

  • Moat Score: 5
  • GF Value™: €83.71 vs. price of €70.00 (16.4% below fair value)
  • GF Score™: 98/100

No single metric tells the full story. See the STU:LHU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LeMaitre Vascular Business Description

Other Exchanges LMAT:USA
Address 63 Second Avenue, Burlington, MA, USA, 01803
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
98GF Score

Get the complete analysis for STU:LHU

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€70.00
Price
€83.71
GF Value